# Sertraline Hydrochloride 100 mg Tablets, Fed

> **NCT00836667** · PHASE1 · COMPLETED · sponsor: **Teva Pharmaceuticals USA** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Zoloft® 100 mg Tablets
- **DRUG:** Sertraline hydrochloride 100 mg Tablets

## Key facts

- **NCT ID:** NCT00836667
- **Lead sponsor:** Teva Pharmaceuticals USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-03
- **Primary completion:** 2002-04
- **Final completion:** 2002-04
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2024-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00836667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00836667, "Sertraline Hydrochloride 100 mg Tablets, Fed". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00836667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*